Procedure mix
Interventional revenue — injections, RFA, stimulator implants, kyphoplasty — carries margins and growth that E&M-and-medication-management models don't. The interventional share of revenue is the first number buyers compute.
Specialty focus · Pain Management
Pain Management Practice Valuation & Brokerage Services in California
Procedure mix, site-of-service economics, and compliance posture decide what a pain practice is worth. We analyze all three before naming a number.
- CVA Certified NACVA Valuation Analyst
- USPAP Compliant Appraisal Reports
- 500+ Valuations 45+ specialties
A Specialty Where Diligence Gets Forensic
Pain management practices can be exceptional earners — interventional procedure economics, ASC or office-based lab revenue, ancillary income — and buyers know it. They also know the specialty's regulatory history, which is why pain practice diligence is the most forensic in medicine: procedure documentation, medical necessity patterns, prescribing data, urine drug testing volumes, and referral relationships all get examined. A valuation that ignores compliance posture isn't conservative or aggressive — it's incomplete. Ours integrates it, because the price a buyer pays is inseparable from the risk they inherit.
Pain Management Practice Valuation
Certified, USPAP-compliant appraisals for sales, buy-ins, divorce, disputes, SBA loans, and estate planning.
Valuation servicesSell Your Pain Management Practice
Confidential, valuation-led brokerage that puts your practice in front of the buyers active in pain management across California.
Brokerage servicesWhat Drives Pain Management Value
Site of service
The same procedure reimburses differently in office, ASC, and HOPD settings. Owned ASC or office-based procedure suites multiply earnings — and we value ASC interests alongside the practice.
Compliance posture
Documented medical necessity, guideline-consistent prescribing, UDT ordering patterns that match clinical logic — these are now value drivers, priced as risk reduction.
Ancillary streams
UDT, durable medical equipment, behavioral health integration — each valued on its own margin and its own compliance footing.
Referral concentration
Pain practices live on referral flows from surgeons, PCPs, and workers' comp channels. Concentration and transferability of those flows feed the discount rate directly.
Buyers in the Pain Space
PE-backed interventional platforms remain active acquirers of well-run California pain practices; health systems acquire for surgical alignment; ASC operators pursue practices with procedure volume to anchor centers. All of them pay premiums for documented compliance and provider leverage — and discount steeply without them. Our valuation and sale process are built around that reality.
Common Engagements
Pre-sale valuations with compliance-aware positioning; PE offer second opinions; ASC unit transactions alongside practice deals; partner disputes over procedure revenue allocation; divorce valuations.
A clear, three-step process
- 1
Discovery Call
A confidential conversation about your practice, your timeline, and the purpose of the valuation. We scope the right report tier before you commit to anything.
- 2
Financial Analysis & Interviews
We interview you and normalize your financials. Owner compensation, one-time expenses, and related-party leases all get restated. Typical turnaround: 1–2 weeks.
- 3
Certified Opinion of Value
You receive a defensible, USPAP-compliant conclusion of value, walked through line by line. The report is documented to withstand scrutiny from a buyer, a court, a partner, or a lender.
What's your interventional mix worth?
Procedure-level analysis, compliance-aware, buyer-calibrated.
Trusted by physicians across California
Real Google reviews from physicians and practice owners we have served. Read them on Google
“As a physician with partnership transaction of medical practice, he was an exceptional to guide me and advise me. He showed not only professionalism but also his eagerness to help and guide me through. Highly recommend him for any business valuation and transaction.”
Dr. Kyong Kim
Partnership transaction
“Fantastic valuation/appraisal specialist. I reached out to Alexey to help me evaluate a medical practice buy-in on short notice. He was able to work me into his schedule and accommodate my timeline despite how busy he was and provided crucial insight into helping me decide my next steps.”
Dr. Xuan Cao
Medical practice buy-in
“They get 5 stars across the board. Alexey was extremely thorough and detailed oriented. He did a deep dive into my practice’s financials, coding and practice history. He was easily approachable and prompt in answering questions and in completing the Appraisal. I am confident in the results and I would highly recommend him to any physician/practice for an appraisal.”
Dr. Robert Sacks
Ophthalmology practice
“I called Nechay as I was navigating the potential of selling my practice, and I had a lot of questions about my various offers for sale. Nechay was so responsive, methodical, and educational. He really allowed me to understand the landscape of selling my practice. He is an effective communicator, very patient on the phone and obviously extremely knowledgeable. I will be hiring him to help complete my transactions!”
Dr. Garima Lal
Evaluating sale offers
“I hired Nechay Appraisals to value my ophthalmology practice last year and couldn’t have been more impressed. From start to finish, Alexey was fantastic to work with. The end result was a highly professional and polished valuation report that provided valuable insights on the current state of my business.”
Dr. David Salvay
Ophthalmology practice valuation
“Alexey has been an excellent asset in evaluating our practice. His experience and practice suggestions have helped us tremendously. His working knowledge of medical practice evaluation and application of these skills is second to none. He is always readily available at a moment’s notice.”
Dr. Elio Vento
Practice evaluation
“Very attentive. Quick to respond. Knowledgeable.”
Dr. Betty Daniels
“Very professional, responsive and creates an excellent report and is accessible. Thank you!”
Dr. Daniel Laroche
“Alexey is very professional and a pleasure to work with. I was under time constraints and he completed his review on time despite those additional pressures.”
Dr. Charles Jackson
“Nechay listened carefully and provided objective feedback tailored to my specific situation. His honest communication and expertise made a complex process much easier. I highly recommend him.”
Dr. Maria Soledad Romero
“Highly recommend! From start to finish, he demonstrated expertise, professionalism, and genuine care. Not only did he deliver a thorough, well-researched valuation report, but he also took the time to explain key findings, offer strategic advice, and answered all our questions — even talked to our accountant and bookkeeper to dig deep into our situation.”
Dr. Alicia Sanchez
Medical practice valuation
“We hired Nechay Appraisals to value our ophthalmology practice the year before last and couldn’t have been more impressed. From start to finish, Alexey was fantastic to work with. He was very organized and very patient with us as we gathered what he needed. Every week he would check in to make sure everything was on track. We are getting ready to utilize his services again and are looking forward to working with him.”
Jenna Keller
Ophthalmology practice valuation
“I greatly appreciate the help from Alexey. The process was easy and the information was invaluable. The data provided was comprehensive and gave me perspective of my company that I was not aware of. I highly recommend Alexey and his company.”
Dr. Linh Ngo
Medical practice valuation
Pain Management questions we hear most
California workers' comp pain revenue can be strong but carries its own fee schedule, lien dynamics, and administrative cost. We value it as a distinct stream — durable for practices with established referral channels, discounted where it's concentrated or lien-dependent.
Often substantially — site-of-service economics flow straight to EBITDA. The analysis verifies accreditation, payer recognition, and utilization headroom, because buyers will pay for documented capacity, not square footage.
Getting ahead of it. We present prescribing and UDT patterns proactively with clinical context in the data room. Buyers fear what they find; they pay for what's already explained.
Yes — implant revenue is high-value but device-cost-heavy and dependent on surgeon skill and rep relationships. We model contribution margin by procedure family rather than gross revenue, which is how sophisticated buyers see it.
Strong Earnings Deserve a Defensible Story
Valuation and exit support for pain practices that run clean.
All inquiries are kept strictly confidential.